NAPLS 2
North American Prodrome Longitudinal Study, phase 2 (Predictors and Mechanisms of Conversion to Psychosis)
Longitudinal brain MRI with clinical, cognitive and blood data from young people at clinical high risk for psychosis and healthy controls, followed for two years to find what predicts and drives conversion to psychosis. Eight sites in the United States and Canada.
Overview
The North American Prodrome Longitudinal Study in its second phase (NAPLS 2, funded by the US National Institute of Mental Health in 2008) followed young people aged 12 to 35 who met criteria for a clinical high risk (prodromal) state for psychosis, along with demographically similar healthy controls. The aims were to test a clinical prediction rule for conversion to psychosis and to study neuroanatomical, electrophysiological, cognitive, hormonal and genetic factors around psychosis onset. The study targeted 720 high-risk participants and 240 controls at eight sites. Imaging data are held in the LONI Image and Data Archive and released on application.
Composition
Cannon et al. (2015) report baseline MRI for 62 high-risk participants who later converted to psychosis, 491 high-risk participants who did not convert and 224 controls, 777 people in total. Of these, 35 converters, 239 non-converters and 135 controls had a usable 12-month or conversion follow-up scan. Forsyth et al. (2014) report working memory fMRI from 166 healthy controls. A traveling-subject substudy scanned 8 healthy adults twice on consecutive days at each of the 8 sites in 2011 (128 sessions).
Acquisition
Imaging, cognition, electrophysiology, cortisol and blood draws were planned at baseline, 12 and 24 months, plus a full assessment at conversion. Five sites (UCLA, Emory, Harvard, UNC, Yale) used Siemens Trio 3 T scanners with 12-channel coils, and three (Zucker Hillside, UCSD, Calgary) used GE 3 T scanners with 8-channel coils. Sagittal 3D T1-weighted images (1 x 1 x 1.2 mm) followed the ADNI protocol, MPRAGE on Siemens and IR-SPGR on GE. Sessions also included a T2-weighted EPI reference image and a Sternberg-style verbal working memory BOLD fMRI run of 182 volumes.
Known limitations
- Counts come from analysis papers, not from a release document, so the archived sample may differ.
- Few converters had a follow-up scan before conversion, and many received antipsychotics between scans.
- Sites differed in participant age, sex ratio and ethnicity.
- The archive's data use terms and study description are not public, so permitted uses cannot be checked before applying.
Cohort
Aggregate numbers from the sources below. Bars are relative to the 777 subjects.
Contrast / sequence
Groups can overlap
- T1-weighted 777 100%
- BOLD fMRI 166 21%
Methods, MRI Scans in Cannon et al. 2015, Biological Psychiatry (progressive cortical thinning in NAPLS 2); Methods, Participants in Forsyth et al. 2014, NeuroImage (multi-site fMRI working memory reliability in NAPLS)
Condition
Groups can overlap
- Psychotic disorder 62 8%
Methods, Subjects in Cannon et al. 2015, Biological Psychiatry (progressive cortical thinning in NAPLS 2)
Field strength
- 3 T 777 100%
Methods, MRI Scans in Cannon et al. 2015, Biological Psychiatry (progressive cortical thinning in NAPLS 2)
License and access
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
A research proposal is reviewed and approved
The study is hosted as project NAPLS in the LONI Image and Data Archive, where access starts with a data use application from an IDA account. The PIs have restricted the public study information on the archive. NAPLS 3 is a separate archive project (NAPLS3).
No published license or data use terms
The data holder has published no license and no data use terms. Any use, sharing or commercial right has to be agreed with the data holder, and nothing can be assumed to be allowed. Default copyright and data protection law still apply.
The data use application and its terms are shown only to logged-in IDA users. Neither the archive page nor the study website publishes a license or data use terms.
What you can do
- Commercial use Not stated
- Not stated
- Train ML models Not stated
- Create derived data Not stated
- Publish results Not stated
What you can share
- Share the data Not stated
- Share derived data Not stated
- Share trained models Not stated
What you must do
- Cite or credit Not stated
- Share alike Not stated
- Sign an agreement Not stated
- Ethics approval Not stated
- Manuscript review Not stated
- Release code Not stated
- Return results Not stated
- Delete after use Not stated
Limits
- No re-identification Not stated
- Location limits Not stated
Citation
Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophrenia Research 142(1-3):77-82 (2012). doi:10.1016/j.schres.2012.09.012
Sources
Every number on this page comes from one of these documents. Each chart names the table or page it is taken from. The raw numbers are in stats.csv.
- Addington et al. 2012, Schizophrenia Research (NAPLS 2 overview and recruitment) paper
- Cannon et al. 2015, Biological Psychiatry (progressive cortical thinning in NAPLS 2) paper
- Forsyth et al. 2014, NeuroImage (multi-site fMRI working memory reliability in NAPLS) paper
- NAPLS website, Background page website